Overall, the four proteins measured in plasma appear to exhibit a similar biomarker profile, with plasma pTau217 most closely associated with the biomarkers of amyloid and tau pathology used in clinic, and standing out as the superior biomarker for AD. The gene discussed is MAPT; the disease is Alzheimer disease.